Literature DB >> 7497870

Prevalence of diabetes and hypertension in a rural population of Bangladesh.

M Abu Sayeed1, A Banu, A R Khan, M Z Hussain.   

Abstract

OBJECTIVE--To determine the prevalence of non-insulin-dependent diabetes mellitus (NIDDM), impaired glucose tolerance (IGT), and hypertension in a rural community of Bangladesh. RESEARCH DESIGN AND METHODS--A cluster sampling of 1,005 subjects > 15 years of age in the rural community of Dohar was investigated. Capillary blood glucose of fasting and 2 h after 75 g oral glucose (2hBG) were estimated. World Health Organization criteria were used for diagnosis of NIDDM and IGT. Blood pressure, height, and weight were also measured. RESULTS--The crude prevalence of NIDDM was 2.1% (men 3.1, women 1.3%) and IGT was 13.3% (men 14.4, women 12.4%). Age-adjusted (30-64 years of age) prevalence was 2.23% (95% confidence interval [CI] 1.01-3.45) for NIDDM and 15.67% (95% CI 12.59-18.75) for IGT. Prevalence of hypertension with systolic blood pressure (sBP) > or = 140 mmHg was 10.5% and with diastolic blood pressure (dBP) > 90 mmHg was 9.0%. Increased age was the risk factor for NIDDM, IGT, and hypertension; whereas increased BMI showed inconsistent association with them. Relative risk for sBP with higher BMI ( < 22.0 vs. > or = 22.1) was 1.94 with CI 1.55-2.43 and for dBP it was 2.2 with CI 1.40-3.46. Correlation of sBP was significant with age, BMI, and 2hBG. Similar correlation was also observed with dBP. CONCLUSIONS--High prevalences of NIDDM, IGT, and hypertension were observed among rural subjects. Increased age was shown to be an important risk factor for all these disorders, whereas BMI-associated risk was significant with NIDDM and hypertension but not with IGT.

Entities:  

Mesh:

Year:  1995        PMID: 7497870     DOI: 10.2337/diacare.18.4.555

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

Review 1.  Hypertension in Bangladesh: a review.

Authors:  A K M Monwarul Islam; Abdullah A S Majumder
Journal:  Indian Heart J       Date:  2012 May-Jun

Review 2.  Type 2 diabetes in youth in South Asia.

Authors:  P A Praveen; S Ram Kumar; Nikhil Tandon
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

3.  Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study.

Authors:  G D Smith; R Greenwood; D Gunnell; P Sweetnam; J Yarnell; P Elwood
Journal:  J Epidemiol Community Health       Date:  2001-12       Impact factor: 3.710

4.  The prevalence of type 2 diabetes and gestational diabetes mellitus in an inner city multi-ethnic population.

Authors:  R N Weijers; D J Bekedam; H Oosting
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

5.  Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey.

Authors:  Shamima Akter; M Mizanur Rahman; Sarah Krull Abe; Papia Sultana
Journal:  Bull World Health Organ       Date:  2014-01-10       Impact factor: 9.408

Review 6.  Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010.

Authors:  Nazmus Saquib; Juliann Saquib; Tahmeed Ahmed; Masuma Akter Khanam; Mark R Cullen
Journal:  BMC Public Health       Date:  2012-06-13       Impact factor: 3.295

7.  Prevalence of type 2 diabetes and impaired glucose regulation with associated cardiometabolic risk factors and depression in an urbanizing rural community in bangladesh: a population-based cross-sectional study.

Authors:  Bishwajit Bhowmik; Sanjida Binte Munir; Israt Ara Hossain; Tasnima Siddiquee; Lien My Diep; Sharif Mahmood; Hajera Mahtab; A K Azad Khan; Akhtar Hussain
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

8.  Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population.

Authors:  Md Nurul Huda; Kazi Shahnoor Alam
Journal:  Int J Nephrol       Date:  2012-07-09

9.  Prevalence of hypertension in the rural adult population of Osun State, southwestern Nigeria.

Authors:  Eo Asekun-Olarinmoye; Po Akinwusi; Wo Adebimpe; Ma Isawumi; Mb Hassan; Oa Olowe; Ob Makanjuola; Co Alebiosu; Ta Adewole
Journal:  Int J Gen Med       Date:  2013-04-26

10.  Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study.

Authors:  Hiroki Ishihara; Yuki Nemoto; Kazutaka Nakamura; Takashi Ikeda; Hidekazu Tachibana; Hironori Fukuda; Kazuhiko Yoshida; Hirohito Kobayashi; Junpei Iizuka; Hiroaki Shimmura; Yasunobu Hashimoto; Toshio Takagi; Hideki Ishida; Tsunenori Kondo; Kazunari Tanabe
Journal:  Target Oncol       Date:  2021-06-26       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.